Abstract
Amino acid sequences of proteins are encoded in nucleic acids composed of four letters, A, G, C, and T(U). However, this four-letter alphabet coding system limits further functionalities of proteins by the twenty letters of amino acids. If we expand the genetic code or develop alternative codes, we could create novel biological systems and biotechnologies by the site-specific incorporation of non-standard amino acids (or unnatural amino acids, unAAs) into proteins. To this end, new codons and their complementary anticodons are required for unAAs. In this review, we introduce the current status of methods to incorporate new amino acids into proteins by in vitro and in vivo translation systems, by focusing on the creation of new codon-anticodon interactions, including unnatural base pair systems for genetic alphabet expansion.
Introduction
The genetic code on earth is ruled by the combinations of three consecutive base sequences as codons corresponding to each amino acid to construct proteins. Sixty-four codons composed of four letters, A, G, C, and T(U), are assigned to the twenty letters of standard amino acids and the three termination signals (stop codons) in translation (Figure 1A). Living organisms maintain the integrity of nucleic acids and proteins within the constraints of the four natural bases and twenty standard amino acids, respectively, by the evolutionary equilibrium between precise information flow through the cognate base pairings, A–T and G–C, and mutations through non-cognate mispairings. However, the limited chemical and biological diversity of these canonical components restricts further improvement toward the development of increased functionalities of nucleic acids and proteins and their biosystems. In fact, living organisms use a wide variety of modified nucleotides and non-standard amino acids (). For example, d-amino acids, instead of the standard l-amino acids, often appear in peptides and proteins (; ; ). Modified nucleotides produced by posttranscriptional modifications of tRNAs increase the efficiency and fidelity of the near cognate codon-anticodon interactions (; Vare et al., 2017; ). Therefore, artificially introducing unnatural bases (UBs) and unnatural amino acids (unAAs) into nucleic acids and proteins could increase their functionalities by expanding the genetic alphabet, and thus lead to the creation of newly engineered organisms.
FIGURE 1
The artificial incorporation of unAAs into proteins through the natural base pair (NBP) or unnatural base pair (UBP) systems requires an orthogonal “bypassing” system for the pre-existing genetic information flow in the central dogma: replication, transcription, and translation. Living organisms have evolved mechanisms to avoid the misincorporation (non-cognate) events of UBs and unAAs and remove these extra components as errors during nucleic acid and protein biosynthesis. Accordingly, in nature, most of the unnatural components in biopolymers are introduced by post-biosynthesis modifications or other biosynthetic mechanisms. To circumvent the proofreading systems of living organisms, researchers have created several “bypassing” schemes by modifying the genetic information flow systems, including the codon table.
Genetic code engineering based on the NBP system has a long research history. In translation, there are several checkpoints for unAA incorporation into proteins (Figure 2). A specific aminoacyl-tRNA synthetase (aaRS) is required for esterifying the unAA to a specific tRNA to generate the unAA-tRNA. Namely, an orthogonal pair of an unAA and its aaRS must be created. The unAA-tRNA should be recognized by elongation factor Tu (EF-Tu), which binds specifically to the aminoacyl-tRNA. Ribosomes must catalyze protein synthesis by incorporating the unAA, using the unAA-tRNA as a substrate. Over the past few decades, several methods to bypass these checkpoints have been developed, for genetic code expansion systems using the existing NBP system, such as the use of stop codons (Type B in Figure 2 and Figure 1C), four-base codon-anticodon interactions (Type C in Figure 2), and sense codon reprogramming (Figures 1D–F), for unAA incorporation into proteins. Importantly, these NBP methods are also employed in UBP systems, and these NBP and UBP systems could potentially be complementary to each other for the further advancement of novel translation systems involving unAA incorporation.
FIGURE 2
In the last quarter century, several UBPs that function as a third base pair in replication, transcription, and/or translation have been developed (Figure 3) (; ; ). DNAs containing UBPs are amplified and transcribed to RNA by polymerases. UBPs also create novel codon-anticodon interactions involving new letters, enabling the site-specific incorporation of unAAs into proteins by ribosome-mediated translation. Additional UBPs could largely expand the existing codon table and theoretically make 152 additional new codons [216 (= 6 × 6 × 6)—64 (= 4 × 4 × 4)] in a six-letter UB system for multiple unAA incorporations (Figure 1G and type D in Figure 2).
FIGURE 3
In this review, we will introduce the methods to create new codon-anticodon interactions for the site-specific incorporation of unAAs into proteins, using NBP and UBP systems. Basic methods for employing the NBP system to expand the codon table will be briefly mentioned. For details of the related topics, including unAA-aminoacylations of tRNAs and eukaryotic translation systems, refer to these reviews (Young and Schultz, 2010; ; ; ; ; ; ; ; ). Since the UBP systems are relatively new, we will describe them in detail. Finally, we will also discuss the combination of the UBP and NBP systems and future perspectives.
Genetic Code Expansion Using the NBP System
First, we will briefly introduce the genetic code expansion using the NBP system, which includes the use of stop codons, four-base codon-anticodon interactions, and sense codon reprogramming in prokaryotic systems.
Use of stop codons: The most common method for site-specific unAA incorporation is the use of stop codons. As a specific case, archaea and eukaryotes also use stop codons for the incorporation of selenocysteine and pyrrolysine into proteins, using suppressor tRNAs. There are three stop codons, amber (UAG), ochre (UAA), and opal (UGA). Among them, amber is the most popular codon for unAA incorporation (Figure 1C and type B in Figure 2), because it has the lowest frequency as a stop codon in Escherichia coli. The stop codon usage in E. coli K12 is 7% UAG, 64% UAA, and 29% UGA (Figure 1B) (Openwetware, 2012). Interestingly, the amber codon usage is also low in other organisms, but it is especially low in E. coli ().
There are two methods for the unAA-aminoacylation of the suppressor tRNA with the CUA anticodon corresponding to the UAG amber codon. One is enzymatic ligation between a suppressor tRNA without the 3′-CA sequence and a chemically synthesized dinucleotide, pCA, which is aminoacylated with an unAA at the 3′-terminus (). This method has been used in in vitro translation systems for site-specific unAA incorporation into proteins (; Noren et al., 1989). The other method is the use of a specific tRNA and aaRS pair, which can be employed in both in vitro and in vivo translation systems. Some of the tRNA-aaRS pairs are specific in each archaeon, prokaryote, and eukaryote, and tRNA-aaRS engineering studies revealed that they can potentially be used as orthogonal pairs in archaea or eukaryotes and assigned for unAAs in bacterial translation systems for unAA incorporation (Wang et al., 2001; ). For example, a tyrosyl-tRNACUA variant and its aaRS from Methanocaldococcus jannaschii and a pyrrolysyl-tRNACUA variant and its aaRS from Methanosarcina barkeri have been used as representative orthogonal pairs for unAA-tRNAs in E. coli and eukaryotic translation systems (Steer and Schimmel, 1999; Wang et al., 2001; Wang and Schultz, 2001; ; Nguyen et al., 2009; Syed et al., 2019).
The issue with using stop codons is that the suppressor tRNA competes with release factors (see the left side in Figure 7A). When the ribosome reaches the stop codon on the mRNA, one of the release factors (RFs) binds to the A site for the ribosome dissociation from the mRNA (Figure 2). For example, RF1 recognizes UAG and competitively inhibits the binding of unAA-tRNACUA to UAG in mRNA, reducing the efficiency of unAA-incorporation into proteins.
To address this issue, Ueda’s team developed the PURE system (Protein synthesis Using Recombinant Element system), in which ribosomes, tRNAs, and translation factors isolated from E. coli are mixed for in vitro translation (Shimizu et al., 2001). By removing RF1 from the recombinant system, the UAG codon becomes free to encode an unAA, which increases the translation efficiency. Only UGA and UAA, which are recognized by RF2, are employed as the stop codons in the system.
Another method for in vivo translation was developed by removing RF1 from living organisms. Sakamoto’s team created an organism (RF1-deficient E. coli strain, RFZERO) by replacing seven essential UAG amber codons (), and then further improved the strategy, by replacing 95 of the 273 UAG codons in E. coli with UAA or UGA stop codons (). In the strain, UAG codons are used for the site-specific incorporation of unAAs. Isaacs’ team replaced all of the UAG codons at 321 positions in the E. coli genome with UAA, and constructed a genomically recoded organism (GRO), the C321.ΔA strain (; ). Interestingly, in addition to efficient unAA incorporation into proteins, the GRO exhibited increased resistance to bacteriophage T7 infection.
Four-base codon-anticodon interactions: As a codon alternative, Sisido’s team developed a four-base codon system, instead of the natural three-base codon system (type C in Figure 2) (; ). In the system, unAA-tRNAs contain four-base anticodons corresponding to the four-base codons in mRNA, and the four-base codon-anticodon interactions function in ribosome-mediated translation. The problem is that the existing tRNAXYZ competes with the four-base anticodon tRNAXYZW and vice versa. To address this issue, they first chose AGGU as the four-base codon, because the AGG codon for arginine is the least used codon in E. coli (AGG: 2%, AGA: 4%, CGG: 10%, CGA: 6%, CGU: 38%, and CGC: 40% for arginine) (Figure 1B). In addition, they embedded a stop codon, such as UAA, in the following frame-shifted position (i.e., AGGUCGU·AAU) (see the left side in Figure 7B). If the AGGU codon was undesirably used by tRNACCU, then the translation would pause at the stop codon (i.e., AGGUCG·UAAU).
In subsequent experiments, they found that GGGU exhibits the most efficient translation efficiency among the four-base codon contexts (). Using two four-base codons, AGGU and CGGG, they succeeded in the site-specific incorporations of two unAAs into streptavidin (). Hohsaka’s team achieved the site-specific labeling of proteins by using dye-conjugated amino acids as unAAs by the four-base codon system (). Schultz’s team comprehensively examined the translation efficiency of the four-codon system and found the best four-codon contexts, AGGA, UAGA, CCCU, and CUAG ().
Toward in vivo translation systems combining the four-base codon system and the amber codon suppression, improved orthogonal pairs of aaRSs and tRNAs with four-base anticodons were developed (; ). Chin’s team evolved a ribosome (ribo-Q1) that efficiently decodes a series of four-base and amber codons to increase the multiple incorporations of unAAs in E. coli. Using this ribo-Q1 system, including AGGA and UAG codons and their orthogonal tRNA-aaRS pairs, they performed the site-specific incorporation of two clickable unAA pairs, azide- and alkyne-containing amino acids, allowing for the cyclization of the generated proteins (). These amino acids are encoded by only one codon (Met: AUG; Trp: UGG), facilitating the replacement of these sense codons with unAAs.
Reprogramming sense codons: Historically, the reassignment of sense codons was first reported for unAA incorporations, in which auxotrophic bacteria were starved for one natural amino acid and supplemented with an unAA. Cowie and Cohen replaced methionine with selenomethionine, using an E. coli methionine auxotroph (). Wong reported a variant of tryptophan-auxotrophic Bacillus subtilis using 4-fluorotryptophan, instead of tryptophan, which was created by gradually decreasing tryptophan and increasing 4-fluorotryptophan in the culture medium (Wong, 1983). Tryptophan is coded with only one codon (UGG) (Figure 1D).
As in the use of the amber codon, rare codons in a synonymous codon family for the same amino acids are useful for unAA assignment as a 21st amino acid. As mentioned above, the rare AGG arginine codon in E. coli was used as an unAA codon (Zeng et al., 2014). Sakamoto’s team developed an E. coli system to incorporate l-homoarginine into proteins, using an engineered pair of an archaeal pyrrolysyl-tRNA synthetase and tRNAPylCCU for the unAA (). Furthermore, they replaced AGG codons in essential genes with other synonymous Arg codons for an efficient in vivo unAA translation system in E. coli.
Another rare codon, AUA, a sense codon (Figure 1B), has also been suggested for unAA incorporation (). The AUA codon in E. coli is recognized by tRNAIle with a modified LAU anticodon (L: lysidine (2-lysyl-cytidine)), enabling L to pair with A in the codon (Suzuki and Miyauchi, 2010). Since this modification is catalyzed by TilS (Soma et al., 2003), the unmodified tRNA with CAU does not recognize the AUA codon, and thus could be used for an unAA in a TilS-depleted E. coli strain (Figure 1D).
The AUG codon is also a candidate for the sense codon reassignment for unAA incorporation () (Figure 1D). The methionine codon AUG is used in two tRNAs: initiator tRNAfMet for the initiation codon and elongator tRNAMet for internal AUG codons. By eliminating the elongator tRNAMet from a methionine auxotrophic E. coli strain, the introduction of a heterologous MetRS–tRNAMet pair from the archaeon Sulfolobus acidocaldarius to the system allows the incorporation of methionine analogs into proteins. The initiator tRNAfMet could also be used for unAA incorporation at the N-terminal position of proteins.
In in vitro translation systems to reassign sense codons, the PURE system is useful to specifically remove the endogenous tRNA and aaRS for each unAA. A representative method for multiple unAA incorporations is the FIT (Flexible In-vitro Translation) system developed by Suga’s team (; Torikai and Suga, 2014). For example, they assigned GUU/C, CGU/C, and GGU/C codons to three different unAAs for the preparation of 23-letter proteins (Figure 1E) (). Their system also used ribozymes called Flexizymes for unAA-aminoacylation of tRNAs (Ohuchi et al., 2007; Passioura et al., 2014). Flexizymes were generated by an in vitro selection method using RNA libraries and an activated unAAs (; Saito and Suga, 2001; Passioura and Suga, 2014). By applying the FIT system to ribosome display methods, they developed a platform system (RaPID, Random non-standard Peptide Integrated Discovery) to generate functional cyclic peptides from peptide libraries containing several unAAs (Passioura et al., 2014). Recently, they established a system for multiple incorporations of β-amino acids into peptides (), in which the tRNAs were engineered by modifying the T-stem and D-arm to increase the binding affinity to EF-Tu (). In this system, they used AUU/C, CAU/C, and UGU/C codons for β-amino acids, as well as AUG for unAAs, to promote the cyclization of the generated peptides. To generate stabilized inhibitor peptides, they recently reported a successful screening using a random peptide library with aromatic cyclic β2,3 amino acids, prepared by ribosomal incorporation ().
In the area of codon reprogramming, Chin’s team established another GRO system by the total synthesis of the E. coli genome with defined synonymous codon compression (Wang et al., 2016; ). They designed and synthesized the 4-Mb E. coli genome, in which 18,214 codons for two serine codons (TCA and TCG) and the TAG amber codon in all of the genes were replaced with AGC, AGT, and TAA, respectively. Furthermore, the genes encoding tRNASerUGA, tRNASerCGA, and RF1 were also removed from the genome. Therefore, the synthesized E. coli (Syn61) uses 61 codons, and the three vacant codons can be used for three unAA codons (Figure 1F).
Genetic Code Expansion Using UBP Systems
Development of UBP systems in vitro: In 1962, Alexander Rich proposed the potential use of a UBP, isoguanine (isoG) and isocytosine (isoC) (Figure 4) with different hydrogen-bonding patterns from those of G–C, for a new codon-anticodon system (Rich, 1962). Even though the codon table was still being deciphered at that time, he imagined that two-base genetic codons, instead of three-base codons, using six-letter genetic alphabets could cover the 20 standard amino acids (20 < 6 × 6). Over 2 decades later, in the late 1980s, Benner’s team designed several UBPs with alternative hydrogen bonding patterns, including the isoG–isoC pair, and chemically synthesized these UB units. Their biological results opened a new world in which the UBPs could be used for replication and transcription, with orthogonal base pairing to the two natural base pairs (Switzer et al., 1989; Piccirilli et al., 1990). In 1992, they reported an in vitro translation system for the site-specific incorporation of 3-iodotyrosine into a peptide, using chemically synthesized mRNA with an (isoC)AG codon and tRNA with a CU(isoG) anticodon (Figure 1G) (). Their efforts toward further UBP development and optimization led to the replicable and transcribable P–Z pair, with higher fidelity than those of the isoG–isoC pair (Figure 4) (Yang et al., 2010; Yang et al., 2011).
FIGURE 4
In the late 1990s, Romesberg’s and Hirao’s teams also started to develop UBPs, based on different concepts, toward practical applications to increase the functionalities of nucleic acids and proteins beyond the canonical four-letter biological system. More than 20 years on, several representative UBPs have become applicable in replication, transcription, or translation in vitro and/or in vivo, including the s–y and Ds–Pa/Ds–Px pairs from Hirao’s team and the NaM–5SICS/NaM–TPT3/CNMO–TPT3/NaM–TAT1 pairs from Romesberg’s team (Figure 4) (; ; ; ; ).
Hirao’s team developed the s–y pair, which functions as a third base pair in transcription (Figure 4). The bulky thienyl group in the s base eliminates its pairing with the natural bases, and the y substrate (yTP) is site-specifically incorporated into RNA opposite s in the DNA template by T7 RNA polymerase (; ). The s–y pair was applied to an in vitro transcription-translation system for the incorporation of unAAs into a specific position of the 185-aa Ras protein. Using an 863-mer DNA template containing s and 3-chlorotyrosyl-tRNACUs (ClTyr-tRNACUs), they coupled the T7 transcription with in vitro translation using an E. coli cell-free system. The LC-MS analysis of the obtained protein confirmed that the yAG codon in the transcribed ras mRNA was decoded by the CUs anticodon of ClTyr-tRNACUs (Figure 1G). Although the yAG codon was decoded by the native Lys-tRNAUUU and Gln-tRNACUG in the absence of ClTyr-tRNACUs, the undesired misincorporation was competitively suppressed by the predominant ClTyr incorporation by ClTyr-tRNACUs (). Even though the yAG codon is closely related to the UAG amber codon, the translation experiments without ClTyr-tRNACUs revealed that the replacement of one of the bases in the termination codons with an unnatural base bypasses the competition with release factors (see Figure 7A).
In the translation system, tRNACUs was prepared by ligation of the 5′-half fragment derived from the native Saccharomyces cerevisiae tRNATyr with the chemically synthesized 3′-half fragment containing CUs (Ohtsuki et al., 1996). The aminoacylation of tRNACUs with ClTyr was performed by S. cerevisiae tyrosyl-tRNA synthetase, which does not recognize the third anticodon position (; Tsunoda et al., 2007), the s position, and aminoacylates S. cerevisiae tRNATyr with tyrosine and tyrosine analogs, such as 3-halotyrosine and DOPA, under specific conditions in the presence of 20% dimethyl sulfoxide and 0.25% Tween-20. In addition, the S. cerevisiae tRNATyr is not aminoacylated by E. coli tRNA synthetase.
Hirao’s team subsequently developed the hydrophobic Ds–Pa/Px pairs, which exhibit high fidelity in replication and transcription, by removing the hydrogen-bonding interactions between pairing bases (; ; ; Yamashige et al., 2012). The Ds–Px pair was applied to high-affinity DNA aptamer generation, thus demonstrating how unnatural components greatly increase nucleic acid functionalities (; ; ; ).
Development of UBP systems in vivo: Romesberg’s team also developed a series of hydrophobic UBPs, such as NaM–5SCIS and NaM–TPT3 (Figure 4), with high fidelity in replication and transcription (; Seo et al., 2009; Seo et al., 2011; ; ). In 2014, using the NaM–5SCIS/TPT3 pairs, Romesberg’s team successfully created an engineered E. coli strain (Figure 5) (Semi-synthetic organism, SSO), which replicates six-letter DNA, using their NaM–5SCIS/TPT3 pairs (). To supply the UB substrates for the living cells, they employed media supplemented with UB-nucleoside triphosphates, dNaMTP and d5SCISTP. To facilitate the import of sufficient amounts of the UB substrates within the cells, the nucleoside triphosphate transporter from Phaeodactylum tricornutum (PtNTT2) was expressed in E. coli [C41 (DE3) strain]. They prepared a plasmid DNA containing the NaM–TPT3 pair through PCR amplification and transformed it into the engineered E. coli expressing PtNTT2. An analysis of the cultured cells revealed the successful replication of the six-letter plasmid DNA with reasonable retention of the NaM–5SICS pair. These results also demonstrated that the UBP was not extensively rejected as a foreign component by the repair system.
FIGURE 5
They further improved this first generation SSO by switching from the original E. coli strain to the BL21 (DE3) strain, which is more suitable for protein expression. The PtNTT2 expression was also optimized because the extremely high expression using T7 RNA polymerase inhibited cell growth. They modified PtNTT2 expression by 1) removing the N-terminal signal peptide (65 aa) of PtNTT2, which is toxic to cell growth, 2) using the optimized codon usage, 3) choosing the best RNA polymerase II promoter sequence, and 4) encoding the truncated PtNTT2 gene within a lacZYA locus in the genome, to avoid expression plasmid copy number variations. The resultant second-generation SSO, called the YZ3 strain, greatly increased the retention rates of their UBPs in replicated DNA within various sequence contexts (Zhang et al., 2017a).
In 2017, their team reported successful in vivo transcription and translation using the YZ3 strain, to decode the AXC or GXC codon (X = NaM) by the corresponding GYU or GYC anticodon (Y = TPT3), thus enabling the site-specific incorporation of unAAs into a recombinant superfolder green fluorescent protein (sfGFP) (Figures 1G, 4) (Zhang et al., 2017b). The YZ3 cells carrying a specific aaRS expression plasmid were additionally transformed by the plasmid DNA containing the NaM–TPT3 pairs, encoding mRNA (X) and tRNA (Y). The induced T7 RNA polymerase expression in the SSO allowed successful T7 transcription of UB-containing mRNA and tRNA, and finally yielded the GFP with an unAA at the AXC or GXC codon position, decoded by unAA-tRNAGYU or unAA-tRNAGYC.
To evaluate the decoding of the new codon-anticodon interactions involving the NaM–TPT3 pair, they first investigated the incorporation of serine into GFP at position 151 (the TAC codon was replaced by the unnatural codon AXC) through E. coli tRNASer (serT), where the anticodon was replaced by the unnatural codon GYT. This system can eliminate complicated situations related to unAAs because E. coli serine aaRS does not recognize the anticodon for tRNA amino acylation (Shimizu et al., 1992). The efficient full-length sfGFP production with 98.5 ± 0.7% incorporation of serine at position 151 was confirmed in the cells transformed with the plasmid encoding both sfGFP(AXC)151 and tRNASerGYT, cultured in the presence of deoxy- and ribo-nucleoside triphosphates (dNaMTP, dTPT3TP, NaMTP, and TPT3TP). After the validation of the unnatural codon-anticodon interactions, they focused on unAA N6-[(2-propynyloxy)carbonyl]-l-lysine (PrK) incorporation in sfGFP(AXC)151 or sfGFP(GXC)151, utilizing a pair of the Methanosarcina mazei tRNAPylGYU or RNAPylGYC and the Methanosarcina barkei pyrrolysyl-tRNA synthetase (PylRS) (Nguyen et al., 2009; ). The PylRS was encoded in a separate plasmid with expression controlled by IPTG induction. For another unAA p-azido-phenylalanine (pAzF) in sfGFP(AXC)151, they utilized an evolved Methanococcus jannaschii TyrRS/tRNATyr pair (i.e. pAzFRS.tRNApAzFGYU) ().
By assessing the UBP retention in plasmid DNAs, the incorporation efficiencies of unAAs, and the cell growth, Romesberg’s team has further optimized the second-generation SSO. First, they examined the in vivo replication mechanisms for UBPs and found that the elimination of RecA and the release of DNA Pol II from SOS repression increased the UBP retention. This study resulted in the third generation SSO with an error-avoidance mechanism, called the ML2 strain [BL21 (DE3) lacZYA::PtNTT2(66-575) ΔrecA polB++] (). Next, they explored a variety of UB substrate analogs for DNA replication and RNA transcription in vivo. They identified the CNMO–TPT3 pair, which is superior to the NaM–TPT3 pair for efficient in vivo DNA replication, and the 5FM–TPT3 and NaM–TAT1 pairs, which are better for the efficient production of GFP with an unAA. The optimized SSO with the dCNMOTP–dTPT3TP/NaMTP–TAT1TP system efficiently produced the GFP with three proximal unAAs, using the AXC-GYU codon-anticodon interaction ().
Using the ML2 strain, Romesberg’s team further identified new codons for efficient production of proteins with unAAs. In 2021, they reported that twenty UB codons are available: seven of the NXN-NYN codon-anticodon interactions (X = NaM, Y = TPT3; including UXC-GYA, CXC-GYG, AXC-GYU, GXU-AYC, GXC-GYC in clonal SSOs) and thirteen of the NNX-XNN interactions (X = NaM; including UUX-XAA, UGX-XGA, CGX-XCG, AGX-XCU in clonal SSOs) (Figure 1G) (; Romesberg, 2021). Interestingly, only NaM, and not TPT3, is acceptable for the codon in the second and third positions, and the third position should be the self NaM–NaM pair, rather than the hetero NaM–TPT3 pair. In addition, they confirmed that at least three of the codon-anticodon interactions, AXC-GYU, GXC-GYC, and AGX-XCU, are orthogonal to each other, allowing for simultaneous decoding in the SSO (). By measuring the transcription fidelity in vivo, they found that the decoding at the ribosome is more sensitive than transcription (Zhou et al., 2020). This might be because the variable codon performance is the total output of the sequence-dependent translation efficiency, although the recognition of the codon-anticodon interaction might differ in eukaryotic cells (Zhou et al., 2019). They are currently exploring the recognition of the NaM–TPT3 pair by the multi-subunit E. coli RNA polymerase II, as compared to the single-subunit T7 RNA polymerase, to create next generation SSOs (; Oh et al., 2021).
Recognition of the codon-anticodon interaction in the bacterial ribosome: For accurate discrimination between cognate and near- or non-cognate aa-tRNAs, the three highly conserved G530, A1492, and A1493 bases in 16S rRNA are prerequisite (Figure 6). To select the cognate tRNA through the minor groove interactions of the codon-anticodon interaction, the two adenine bases are flipped out from the internal loop of helix 44 of 16S RNA in the 30S ribosomal subunit (Ogle et al., 2001; Ramakrishnan, 2002; ). At the first position of the codon-anticodon, A1493 forms a type I A-minor motif interactionboth the O2’ and N3 of A1493 are located in the minor groove of the first position, maximizing the number of hydrogen bonds that can be formed (Nissen et al., 2001; Ogle et al., 2001). At the second position, A1492 and G530 are tightly packed in the minor groove of the codon-anticodon (a type II A-minor motif interaction) (Nissen et al., 2001; Ogle et al., 2001), but do not directly interact with the base moieties. Thus, the second position would accommodate small structural differences in the base pair (). The third position has more open space and is less monitored by the ribosome.
FIGURE 6
Recent in vitro translation studies using RNA nucleobase derivatives in the mRNA demonstrated that the hydrogen-bonding interaction between the N1 of purines and the N3 of pyrimidines is sufficient for decoding at the first or second position. At the third “wobble” position, an adequate stacking force, not limited to the hydrogen-bonding interactions, could be essential (). The UBP studies clearly demonstrated that the acceptance of the hydrogen-bonded isoC-isoG and y–s pairs at the first codon-anticodon position might be reasonable, since their UB pairing structures effectively mimic the natural Watson-Crick base pairing geometry. In contrast, the non-hydrogen-bonded NaM–TPT3 pair at the first position might adopt a cross-strand intercalated structure (), as found in the free DNA duplex form. The UBP is quite different from the Watson-Crick like structure found in the polymerase active site (; ), which might prevent recognition as a cognate base pair. Interestingly, although the previous UBP study suggested that at least the hydrogen-bonding interaction between the N1 of purines and the N3 of pyrimidines at the second position is required for the decoding, the NaM–TPT3 pair is well accepted as cognate. Together with the acceptance of the self NaM–NaM pair at the third position, these results indicate that complementary packing and hydrophobic forces can “bypass” the requirement for precise decoding at the second and third positions (). However, the reason why only NaM, and not TPT3, is acceptable for mRNA remains unclear.
The discrimination mechanisms of cognate and non-cognate pairs by DNA and RNA polymerases may be similar to those of the decoding process. Both polymerases and the ribosome 30S subunit undergo a structural rearrangement from an open to a closed form in the cognate pairing, through interactions with the minor groove of the Watson-Crick base pairing (Ogle et al., 2002). Further detailed translation studies using other UBPs might elucidate the unknown mechanisms and driving forces by which the RNA-based decoding system precisely discriminates the cognate and non-cognate pairing, commonly and/or differently from those in polymerases.
Therapeutic Applications of Engineered Proteins by Genetic Code Expansion
These translation systems by genetic code expansion have facilitated the rational design and optimization of proteins suitable for therapeutic applications, by improving the biological functions and pharmacokinetics of biologics in a manner resembling the pursuit of small-molecule therapeutics. Several macrocyclic peptides containing unAAs, including those generated by the ribosomal translation system, are now undergoing clinical tests (Vinogradov et al., 2019). Currently, several engineered proteins generated by these technologies are in pre-clinical and clinical trials as protein therapeutics. Representatives are, but not limited to, PEGylated interleukin-2 (SAR44425, THOR-707) (), PEGylated fibroblast growth factor 21 (BMS-986036, pegbelfermin), Anti-HER2 antibody-drug conjugate (a site-specific Herceptin-monomethyl auristatin D (MMAD) conjugate, ARX788) (Sun et al., 2014), and anti-CD3 Folate Bi-Specific (Sun et al., 2014).
The recombinant human cytokine interleukin-2 (rhIL-2, or aldesleukin) was originally approved as a drug for immune oncology targeting renal cell carcinoma (; ). However, rhIL-2/aldesleukin therapy, targeting the stimulation of tumor immune responses through CD8+ effector T and natural-killer cells, which express the IL-2 receptor beta and gamma subunit complex (IL-2 Rβγ), has been limited due to the short half-life and off-target effects resulting from its interaction with the IL-2 receptor alpha subunit (IL-2 Rα). Scientists at Synthorx (founded by Romesberg in 2014, acquired by Sanofi in 2019) used Romesberg’s SSO (YZ3 strain) to successfully identify a suitable PEGylated position (P65) in IL-2 from 10 candidates (K35, R38, T41, F42, K43, Y45, F62, P65, E68, and V69) and addressed the above two issues. These analyses resulted in the development of THOR-707, the IL-2 compound with an unAA at position 65, followed by further modification with a 30 kDa mPEG, which retained the binding ability to IL-2 Rβγ but lacked that to the undesired IL-2 Rαβγ, and showed an extended half-life (; Ptacin et al., 2021; Romesberg, 2021). THOR-707 is currently in a phase I/II study, not only as a monotherapeutic, but also in combination with a checkpoint inhibitor (pembrolizumab or cemiplimab) (Romesberg, 2021).
Conclusion and Future Perspective
Continuous and comprehensive research on genetic alphabet rearrangement and expansion technologies has largely improved the unAA incorporation fidelity and efficiency and created new organisms. Even hydrophobic UBPs without any clear hydrogen-bond interactions between pairing bases can function as new letters of DNA and RNA, for information storage and retrieval in in vivo systems (SSOs). Recent breakthroughs in UBP development as a third base pair have created novel genetic alphabet systems of DNA and RNA, providing the expanded codon table in translation, which can bypass the checkpoints of the native translation system. The new UB-codons related to the stop codons, such as isoCAG, yAG, and UGNaM, predominantly interact with their UB-anticodons and prevent the interaction with RF (Figure 7A.
FIGURE 7
The UBP systems could improve the current NBP genetic code expansion systems. For example, the introduction of UBs into four-base codon systems might prevent the competition with the native tRNAs with three-base anticodons (Figure 7B). As shown in Romesberg’s results, embedding the UB in the middle of a codon (for example, AXC and GXC) would maximize the UB’s discrimination capabilities in decoding. A novel pair of tRNA and aaRS for unAAs could be created by introducing UBs into tRNAs and unAAs into aaRSs (Figure 7C) (Young and Schultz, 2018), as UB-containing nucleic acid aptamers significantly increase the affinities and specificities with target proteins (). Such novel pairs would enhance the simultaneous incorporation of different multiple unAAs, as well as the known tRNA/aaRS pairs (; ; Tanrikulu et al., 2009; ; ; ). Flexizymes could also improve the efficiency and specificity of tRNA aminoacylation by introducing UBs, although the UBP applications to ribozymes have not yet been reported. The current Flexizymes recognize tRNAs by the interaction between the terminal GGU sequence of Flexizyme and the terminal ACCA sequence of tRNAs, and thus aminoacylate tRNAs non-specifically (Figure 7D). One possible improvement would be the introduction of a UBP (X-Y) to the terminal position (GGX) of Flexizyme and to the discriminator base (YCC) in tRNAs. Further research for the introduction of UBs (UBPs) and unAAs into biopolymers (DNA, RNA, and protein) would yield not only fruitful findings in translation mechanisms but also novel protein therapeutics, empowered by the cooperative fusion of chemistry and biology. Furthermore, the UBP-unAA systems have the potential to create novel organisms with increased functionalities, such as enhanced productivity of useful materials and highly sensitive sensors for detection. Thus, the combination of the NBP and UBP systems could further expand the capability of genetic code engineering for multiple unAA incorporations.
Currently, only the UBPs developed by Romesberg’s team have been demonstrated in the in vivo system. The potentials of other UBPs, such as Z–P and Ds–Px, for in vivo systems are still unknown. The fidelity and toxicity of UBPs and UB materials and the limitation of the number of UB-codons available in SSOs are important issues. Romesberg’s team demonstrated that the use of a Cas9-based editing system allowed the increased retention (fidelity in replication) of their UBPs in living cells (Zhang et al., 2017a), but the additionally expressed sgRNAs might interfere with efficient translation. Although in vitro studies revealed that the replication fidelities of some UBPs are more than 99.8% per duplication, there is still room for further improvement of the specificity and stability of UBPs to reduce the mutation rates in replication, transcription, and translation. The toxicity of continuously supplementing unnatural base substrates as a third base pair for long term cultures and the possible increase in mutations have not been fully elucidated. The current UBP translation systems have mainly been studied in prokaryotic systems. In the future, UBP studies will be expanded to eukaryotic systems (Zhou et al., 2019) and provide further information and possibilities.
UBP research and its applications have only just begun. Nevertheless, the improvements of UBP systems have opened the door to novel biotechnologies, as described here. Replication with non-hydrogen bonded UBPs in the E. coli genome has also become an achievable target (). However, as compared to the NBP system, the utility of the current UBP systems is still limited due to the comparatively lower fidelity and efficiency with some sequence biases, which increase the mutation rates and change the evolutionary equilibrium of the system and SSOs. As for the codon-anticodon interactions, non-hydrogen bonded UBPs are less stable, but can be used in translation within the limits of the codon usage. Extensive studies using UBPs and modified nucleotides, including the further development of UBPs and the combination with NBP systems, might reveal the unknown secrets of the current life system.
Statements
Author contributions
Both MK and IH wrote the manuscript and figures by introducing their ideas.
Funding
This work was supported by the Institute of Bioengineering and Bioimaging (Biomedical Research Council, Agency for Science, Technology and Research, Singapore).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AbeR.ShiragaK.EbisuS.TakagiH.HohsakaT. (2010). Incorporation of Fluorescent Non-natural Amino Acids into N-Terminal Tag of Proteins in Cell-free Translation and its Dependence on Position and Neighboring Codons. J. Biosci. Bioeng.110, 32–38. 10.1016/j.jbiosc.2010.01.003
2
AgostiniF.VöllerJ. S.KokschB.Acevedo‐RochaC. G.KubyshkinV.BudisaN. (2017). Biocatalysis with Unnatural Amino Acids: Enzymology Meets Xenobiology. Angew. Chem. Int. Ed.56, 9680–9703. 10.1002/anie.201610129
3
AgrisP. F.VendeixF. A. P.GrahamW. D. (2007). tRNA's Wobble Decoding of the Genome: 40 Years of Modification. J. Mol. Biol.366, 1–13. 10.1016/j.jmb.2006.11.046
4
AmbrogellyA.PaliouraS.SöllD. (2007). Natural Expansion of the Genetic Code. Nat. Chem. Biol.3, 29–35. 10.1038/nchembio847
5
BainJ. D.DialaE. S.GlabeC. G.DixT. A.ChamberlinA. R. (1989). Biosynthetic Site-specific Incorporation of a Non-natural Amino Acid into a Polypeptide. J. Am. Chem. Soc.111, 8013–8014. 10.1021/ja00202a052
6
BainJ. D.SwitzerC.ChamberlinR.BennerS. A. (1992). Ribosome-mediated Incorporation of a Non-standard Amino Acid into a Peptide through Expansion of the Genetic Code. Nature356, 537–539. 10.1038/356537a0
7
BelinD.PuigbòP. (2022). Why Is the UAG (Amber) Stop Codon Almost Absent in Highly Expressed Bacterial Genes?Life (Basel)12, 431. 10.3390/life12030431
8
BennerS. A.KaralkarN. B.HoshikaS.LaosR.ShawR. W.MatsuuraM.et al (2016). Alternative Watson-Crick Synthetic Genetic Systems. Cold Spring Harb. Perspect. Biol.8, a023770. 10.1101/cshperspect.a023770
9
BetzK.MalyshevD. A.LavergneT.WelteW.DiederichsK.DwyerT. J.et al (2012). KlenTaq Polymerase Replicates Unnatural Base Pairs by Inducing a Watson-Crick Geometry. Nat. Chem. Biol.8, 612–614. 10.1038/nchembio.966
10
BetzK.MalyshevD. A.LavergneT.WelteW.DiederichsK.RomesbergF. E.et al (2013). Structural Insights into DNA Replication without Hydrogen Bonds. J. Am. Chem. Soc.135, 18637–18643. 10.1021/ja409609j
11
BohlkeN.BudisaN. (2014). Sense Codon Emancipation for Proteome-wide Incorporation of Noncanonical Amino Acids: Rare Isoleucine Codon AUA as a Target for Genetic Code Expansion. FEMS Microbiol. Lett.351, 133–144. 10.1111/1574-6968.12371
12
BrustadE.BusheyM. L.BrockA.ChittuluruJ.SchultzP. G. (2008). A Promiscuous Aminoacyl-tRNA Synthetase that Incorporates Cysteine, Methionine, and Alanine Homologs into Proteins. Bioorg. Med. Chem. Lett.18, 6004–6006. 10.1016/j.bmcl.2008.09.050
13
BudisaN. (2013). Expanded Genetic Code for the Engineering of Ribosomally Synthetized and Post-translationally Modified Peptide Natural Products (RiPPs). Curr. Opin. Biotechnol.24, 591–598. 10.1016/j.copbio.2013.02.026
14
ChatterjeeA.SunS. B.FurmanJ. L.XiaoH.SchultzP. G. (2013). A Versatile Platform for Single- and Multiple-Unnatural Amino Acid Mutagenesis in Escherichia coli. Biochemistry52, 1828–1837. 10.1021/bi4000244
15
ChatterjeeA.XiaoH.SchultzP. G. (2012). Evolution of Multiple, Mutually Orthogonal Prolyl-tRNA Synthetase/tRNA Pairs for Unnatural Amino Acid Mutagenesis in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A.109, 14841–14846. 10.1073/pnas.1212454109
16
ChinJ. W.CroppT. A.AndersonJ. C.MukherjiM.ZhangZ.SchultzP. G. (2003). An Expanded Eukaryotic Genetic Code. Science301, 964–967. 10.1126/science.1084772
17
ChinJ. W.MartinA. B.KingD. S.WangL.SchultzP. G. (2002a). Addition of a Photocrosslinking Amino Acid to the Genetic Code of Escherichia coli. Proc. Natl. Acad. Sci. U.S.A.99, 11020–11024. 10.1073/pnas.172226299
18
ChinJ. W.SantoroS. W.MartinA. B.KingD. S.WangL.SchultzP. G. (2002b). Addition of P-Azido-L-Phenylalanine to the Genetic Code of Escherichia coli. J. Am. Chem. Soc.124, 9026–9027. 10.1021/ja027007w
19
ChowC. M.RajbhandaryU. L. (1993). Saccharomyces cerevisiae Cytoplasmic Tyrosyl-tRNA Synthetase Gene. Isolation by Complementation of a Mutant Escherichia coli Suppressor tRNA Defective in Aminoacylation and Sequence Analysis. J. Biol. Chem.268, 12855–12863. 10.1016/s0021-9258(18)31466-2
20
ChungC. Z.AmikuraK.SöllD. (2020). Using Genetic Code Expansion for Protein Biochemical Studies. Front. Bioeng. Biotechnol.8, 598577. 10.3389/fbioe.2020.598577
21
CochellaL.BrunelleJ. L.GreenR. (2007). Mutational Analysis Reveals Two Independent Molecular Requirements during Transfer RNA Selection on the Ribosome. Nat. Struct. Mol. Biol.14, 30–36. 10.1038/nsmb1183
22
CowieD. B.CohenG. N. (1957). Biosynthesis by Escherichia coli of Active Altered Proteins Containing Selenium Instead of Sulfur. Biochimica Biophysica Acta26, 252–261. 10.1016/0006-3002(57)90003-3
23
De La TorreD.ChinJ. W. (2021). Reprogramming the Genetic Code. Nat. Rev. Genet.22, 169–184. 10.1038/s41576-020-00307-7
24
De SimoneA.Acevedo-RochaC. G.HoeslM. G.BudisaN. (2016). Towards Reasignment of the Methionine Codon AUG to Two Different Noncanonical Amino Acids in Bacterial Translation. Croat. Chem. Acta89, 243–253. 10.5562/cca2915
25
DingW.ZhaoH.ChenY.ZhangB.YangY.ZangJ.et al (2020). Chimeric Design of Pyrrolysyl-tRNA Synthetase/tRNA Pairs and Canonical Synthetase/tRNA Pairs for Genetic Code Expansion. Nat. Commun.11, 3154. 10.1038/s41467-020-16898-y
26
FeldmanA. W.DienV. T.KaradeemaR. J.FischerE. C.YouY.AndersonB. A.et al (2019). Optimization of Replication, Transcription, and Translation in a Semi-synthetic Organism. J. Am. Chem. Soc.141, 10644–10653. 10.1021/jacs.9b02075
27
FischerE. C.HashimotoK.ZhangY.FeldmanA. W.DienV. T.KaradeemaR. J.et al (2020). New Codons for Efficient Production of Unnatural Proteins in a Semisynthetic Organism. Nat. Chem. Biol.16, 570–576. 10.1038/s41589-020-0507-z
28
FredensJ.WangK.De La TorreD.FunkeL. F. H.RobertsonW. E.ChristovaY.et al (2019). Total Synthesis of Escherichia coli with a Recoded Genome. Nature569, 514–518. 10.1038/s41586-019-1192-5
29
FujiwaraT.KimotoM.SugiyamaH.HiraoI.YokoyamaS. (2001). Synthesis of 6-(2-thienyl)purine Nucleoside Derivatives that Form Unnatural Base Pairs with Pyridin-2-One Nucleosides. Bioorg. Med. Chem. Lett.11, 2221–2223. 10.1016/s0960-894x(01)00415-2
30
FutamiK.KimotoM.LimY. W. S.HiraoI. (2019). Genetic Alphabet Expansion Provides Versatile Specificities and Activities of Unnatural-Base DNA Aptamers Targeting Cancer Cells. Mol. Ther. Nucleic Acids14, 158–170. 10.1016/j.omtn.2018.11.011
31
GotoY.SugaH. (2009). Translation Initiation with Initiator tRNA Charged with Exotic Peptides. J. Am. Chem. Soc.131, 5040–5041. 10.1021/ja900597d
32
HashimotoK.FischerE. C.RomesbergF. E. (2021). Efforts toward Further Integration of an Unnatural Base Pair into the Biology of a Semisynthetic Organism. J. Am. Chem. Soc.143, 8603–8607. 10.1021/jacs.1c03860
33
HeckS. D.SiokC. J.KrapchoK. J.KelbaughP. R.ThadeioP. F.WelchM. J.et al (1994). Functional Consequences of Posttranslational Isomerization of Ser 46 in a Calcium Channel Toxin. Science266, 1065–1068. 10.1126/science.7973665
34
HecklerT. G.ChangL. H.ZamaY.NakaT.ChorghadeM. S.HechtS. M. (1984). T4 RNA Ligase Mediated Preparation of Novel "chemically Misacylated" tRNAPheS. Biochemistry23, 1468–1473. 10.1021/bi00302a020
35
HiraoI.KimotoM.MitsuiT.FujiwaraT.KawaiR.SatoA.et al (2006). An Unnatural Hydrophobic Base Pair System: Site-specific Incorporation of Nucleotide Analogs into DNA and RNA. Nat. Methods3, 729–735. 10.1038/nmeth915
36
HiraoI.KimotoM. (2012). Unnatural Base Pair Systems toward the Expansion of the Genetic Alphabet in the Central Dogma. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci.88, 345–367. 10.2183/pjab.88.345
37
HiraoI.MitsuiT.KimotoM.YokoyamaS. (2007). An Efficient Unnatural Base Pair for PCR Amplification. J. Am. Chem. Soc.129, 15549–15555. 10.1021/ja073830m
38
HiraoI.OhtsukiT.FujiwaraT.MitsuiT.YokogawaT.OkuniT.et al (2002). An Unnatural Base Pair for Incorporating Amino Acid Analogs into Proteins. Nat. Biotechnol.20, 177–182. 10.1038/nbt0202-177
39
HoernesT. P.FaserlK.JuenM. A.KremserJ.GasserC.FuchsE.et al (2018). Translation of Non-standard Codon Nucleotides Reveals Minimal Requirements for Codon-Anticodon Interactions. Nat. Commun.9, 4865. 10.1038/s41467-018-07321-8
40
HohsakaT.AshizukaY.MurakamiH.SisidoM. (1996). Incorporation of Nonnatural Amino Acids into Streptavidin through In Vitro Frame-Shift Suppression. J. Am. Chem. Soc.118, 9778–9779. 10.1021/ja9614225
41
HohsakaT.AshizukaY.SasakiH.MurakamiH.SisidoM. (1999). Incorporation of Two Different Nonnatural Amino Acids Independently into a Single Protein through Extension of the Genetic Code. J. Am. Chem. Soc.121, 12194–12195. 10.1021/ja992204p
42
HohsakaT.SisidoM. (2002). Incorporation of Non-natural Amino Acids into Proteins. Curr. Opin. Chem. Biol.6, 809–815. 10.1016/s1367-5931(02)00376-9
43
ItaliaJ. S.AddyP. S.WrobelC. J. J.CrawfordL. A.LajoieM. J.ZhengY.et al (2017). An Orthogonalized Platform for Genetic Code Expansion in Both Bacteria and Eukaryotes. Nat. Chem. Biol.13, 446–450. 10.1038/nchembio.2312
44
IwaneY.HitomiA.MurakamiH.KatohT.GotoY.SugaH. (2016). Expanding the Amino Acid Repertoire of Ribosomal Polypeptide Synthesis via the Artificial Division of Codon Boxes. Nat. Chem.8, 317–325. 10.1038/nchem.2446
45
IwaneY.KimuraH.KatohT.SugaH. (2021). Uniform Affinity-Tuning of N-Methyl-Aminoacyl-tRNAs to EF-Tu Enhances Their Multiple Incorporation. Nucleic Acids Res.49, 10807–10817. 10.1093/nar/gkab288
46
KatohT.SengokuT.HirataK.OgataK.SugaH. (2020). Ribosomal Synthesis and De Novo Discovery of Bioactive Foldamer Peptides Containing Cyclic β-amino Acids. Nat. Chem.12, 1081–1088. 10.1038/s41557-020-0525-1
47
KatohT.SugaH. (2022). In Vitro Selection of Foldamer-like Macrocyclic Peptides Containing 2-Aminobenzoic Acid and 3-Aminothiophene-2-Carboxylic Acid. J. Am. Chem. Soc.144, 2069–2072. 10.1021/jacs.1c12133
48
KimotoM.HiraoI. (2020). Genetic Alphabet Expansion Technology by Creating Unnatural Base Pairs. Chem. Soc. Rev.49, 7602–7626. 10.1039/d0cs00457j
49
KimotoM.KawaiR.MitsuiT.YokoyamaS.HiraoI. (2009). An Unnatural Base Pair System for Efficient PCR Amplification and Functionalization of DNA Molecules. Nucleic Acids Res.37, e14. e14. 10.1093/nar/gkn956
50
KimotoM.YamashigeR.MatsunagaK.YokoyamaS.HiraoI. (2013). Generation of High-Affinity DNA Aptamers Using an Expanded Genetic Alphabet. Nat. Biotechnol.31, 453–457. 10.1038/nbt.2556
51
KlapperJ. A.DowneyS. G.SmithF. O.YangJ. C.HughesM. S.KammulaU. S.et al (2008). High‐dose Interleukin‐2 for the Treatment of Metastatic Renal Cell Carcinoma. Cancer113, 293–301. 10.1002/cncr.23552
52
KohC. S.SarinL. P. (2018). Transfer RNA Modification and Infection - Implications for Pathogenicity and Host Responses. Biochimica Biophysica Acta (BBA) - Gene Regul. Mech.1861, 419–432. 10.1016/j.bbagrm.2018.01.015
53
KreilG. (1994). Conversion of L- to D-Amino Acids: a Posttranslational Reaction. Science266, 996–997. 10.1126/science.7973683
54
KreilG. (1997). D-amino Acids in Animal Peptides. Annu. Rev. Biochem.66, 337–345. 10.1146/annurev.biochem.66.1.337
55
KriegC.LétourneauS.PantaleoG.BoymanO. (2010). Improved IL-2 Immunotherapy by Selective Stimulation of IL-2 Receptors on Lymphocytes and Endothelial Cells. Proc. Natl. Acad. Sci. U.S.A.107, 11906–11911. 10.1073/pnas.1002569107
56
KubyshkinV.Acevedo-RochaC. G.BudisaN. (2018). On Universal Coding Events in Protein Biogenesis. Biosystems164, 16–25. 10.1016/j.biosystems.2017.10.004
57
LajoieM. J.KosuriS.MosbergJ. A.GreggC. J.ZhangD.ChurchG. M. (2013a). Probing the Limits of Genetic Recoding in Essential Genes. Science342, 361–363. 10.1126/science.1241460
58
LajoieM. J.RovnerA. J.GoodmanD. B.AerniH.-R.HaimovichA. D.KuznetsovG.et al (2013b). Genomically Recoded Organisms Expand Biological Functions. Science342, 357–360. 10.1126/science.1241459
59
LajoieM. J.SöllD.ChurchG. M. (2016). Overcoming Challenges in Engineering the Genetic Code. J. Mol. Biol.428, 1004–1021. 10.1016/j.jmb.2015.09.003
60
LavergneT.DegardinM.MalyshevD. A.QuachH. T.DhamiK.OrdoukhanianP.et al (2013). Expanding the Scope of Replicable Unnatural DNA: Stepwise Optimization of a Predominantly Hydrophobic Base Pair. J. Am. Chem. Soc.135, 5408–5419. 10.1021/ja312148q
61
LedbetterM. P.KaradeemaR. J.RomesbergF. E. (2018). Reprograming the Replisome of a Semisynthetic Organism for the Expansion of the Genetic Alphabet. J. Am. Chem. Soc.140, 758–765. 10.1021/jacs.7b11488
62
LeeN.BesshoY.WeiK.SzostakJ. W.SugaH. (2000). Ribozyme-catalyzed tRNA Aminoacylation. Nat. Struct. Biol.7, 28–33. 10.1038/71225
63
MaglieryT. J.AndersonJ. C.SchultzP. G. (2001). Expanding the Genetic Code: Selection of Efficient Suppressors of Four-Base Codons and Identification of "shifty" Four-Base Codons with a Library Approach in Escherichia coli11Edited by M. Gottesman. J. Mol. Biol.307, 755–769. 10.1006/jmbi.2001.4518
64
MalyshevD. A.DhamiK.LavergneT.ChenT.DaiN.FosterJ. M.et al (2014). A Semi-synthetic Organism with an Expanded Genetic Alphabet. Nature509, 385–388. 10.1038/nature13314
65
MalyshevD. A.DhamiK.QuachH. T.LavergneT.OrdoukhanianP.TorkamaniA.et al (2012). Efficient and Sequence-independent Replication of DNA Containing a Third Base Pair Establishes a Functional Six-Letter Genetic Alphabet. Proc. Natl. Acad. Sci. U.S.A.109, 12005–12010. 10.1073/pnas.1205176109
66
MalyshevD. A.RomesbergF. E. (2015). The Expanded Genetic Alphabet. Angew. Chem. Int. Ed.54, 11930–11944. 10.1002/anie.201502890
67
MalyshevD. A.SeoY. J.OrdoukhanianP.RomesbergF. E. (2009). PCR with an Expanded Genetic Alphabet. J. Am. Chem. Soc.131, 14620–14621. 10.1021/ja906186f
68
ManandharM.ChunE.RomesbergF. E. (2021). Genetic Code Expansion: Inception, Development, Commercialization. J. Am. Chem. Soc.143, 4859–4878. 10.1021/jacs.0c11938
69
MatsunagaK.KimotoM.HiraoI. (2017). High-affinity DNA aptamer generation targeting von Willebrand factor A1-domain by genetic alphabet expansion for systematic evolution of ligands by exponential enrichment using two types of libraries composed of five different bases. J. Am. Chem. Soc.139, 324–334. 10.1021/jacs.6b10767
70
MatsunagaK.KimotoM.LimV. W.TanH. P.WongY. Q.SunW.et al (2021). High-affinity Five/six-Letter DNA Aptamers with Superior Specificity Enabling the Detection of Dengue NS1 Protein Variants beyond the Serotype Identification. Nucleic Acids Res.49, 11407–11424. 10.1093/nar/gkab515
71
MelnikovS. V.SöllD. (2019). Aminoacyl-tRNA Synthetases and tRNAs for an Expanded Genetic Code: What Makes Them Orthogonal?Int. J. Mol. Sci.20, 1929. 10.3390/ijms20081929
72
MukaiT.HayashiA.IrahaF.SatoA.OhtakeK.YokoyamaS.et al (2010). Codon Reassignment in the Escherichia coli Genetic Code. Nucleic Acids Res.38, 8188–8195. 10.1093/nar/gkq707
73
MukaiT.HoshiH.OhtakeK.TakahashiM.YamaguchiA.HayashiA.et al (2015a). Highly Reproductive Escherichia coli Cells with No Specific Assignment to the UAG Codon. Sci. Rep.5, 9699. 10.1038/srep09699
74
MukaiT.LajoieM. J.EnglertM.SöllD. (2017). Rewriting the Genetic Code. Annu. Rev. Microbiol.71, 557–577. 10.1146/annurev-micro-090816-093247
75
MukaiT.YamaguchiA.OhtakeK.TakahashiM.HayashiA.IrahaF.et al (2015b). Reassignment of a Rare Sense Codon to a Non-canonical Amino Acid inEscherichia Coli. Nucleic Acids Res.43, 8111–8122. 10.1093/nar/gkv787
76
MurakamiH.HohsakaT.AshizukaY.SisidoM. (1998). Site-directed Incorporation of P-Nitrophenylalanine into Streptavidin and Site-To-Site Photoinduced Electron Transfer from a Pyrenyl Group to a Nitrophenyl Group on the Protein Framework. J. Am. Chem. Soc.120, 7520–7529. 10.1021/ja971890u
77
NeumannH.WangK.DavisL.Garcia-AlaiM.ChinJ. W. (2010). Encoding Multiple Unnatural Amino Acids via Evolution of a Quadruplet-Decoding Ribosome. Nature464, 441–444. 10.1038/nature08817
78
NguyenD. P.LusicH.NeumannH.KapadnisP. B.DeitersA.ChinJ. W. (2009). Genetic Encoding and Labeling of Aliphatic Azides and Alkynes in Recombinant Proteins via a Pyrrolysyl-tRNA Synthetase/tRNACUA Pair and Click Chemistry. J. Am. Chem. Soc.131, 8720–8721. 10.1021/ja900553w
79
NissenP.IppolitoJ. A.BanN.MooreP. B.SteitzT. A. (2001). RNA Tertiary Interactions in the Large Ribosomal Subunit: the A-Minor Motif. Proc. Natl. Acad. Sci. U.S.A.98, 4899–4903. 10.1073/pnas.081082398
80
NorenC. J.Anthony-CahillS. J.GriffithM. C.SchultzP. G. (1989). A General Method for Site-specific Incorporation of Unnatural Amino Acids into Proteins. Science244, 182–188. 10.1126/science.2649980
81
OgleJ. M.BrodersenD. E.ClemonsW. M.Jr.TarryM. J.CarterA. P.RamakrishnanV. (2001). Recognition of Cognate Transfer RNA by the 30 S Ribosomal Subunit. Science292, 897–902. 10.1126/science.1060612
82
OgleJ. M.MurphyF. V.TarryM. J.RamakrishnanV. (2002). Selection of tRNA by the Ribosome Requires a Transition from an Open to a Closed Form. Cell111, 721–732. 10.1016/s0092-8674(02)01086-3
83
OhJ.ShinJ.UnartaI. C.WangW.FeldmanA. W.KaradeemaR. J.et al (2021). Transcriptional Processing of an Unnatural Base Pair by Eukaryotic RNA Polymerase II. Nat. Chem. Biol.17, 906–914. 10.1038/s41589-021-00817-3
84
OhtsukiT.KawaiG.WatanabeY.KitaK.NishikawaK.WatanabeK. (1996). Preparation of Biologically Active Ascaris suum Mitochondrial tRNAMet with a TV-Replacement Loop by Ligation of Chemically Synthesized RNA Fragments. Nucleic Acids Res.24, 662–667. 10.1093/nar/24.4.662
85
OhuchiM.MurakamiH.SugaH. (2007). The Flexizyme System: a Highly Flexible tRNA Aminoacylation Tool for the Translation Apparatus. Curr. Opin. Chem. Biol.11, 537–542. 10.1016/j.cbpa.2007.08.011
86
Openwetware (2012). Escherichia coli/Codon Usage [Online]. Available at: https://openwetware.org/wiki/Escherichia_coli/Codon_usage (Accessed August 15, 2012).
87
PassiouraT.SugaH. (2014). Flexizymes, Their Evolutionary History and Diverse Utilities. Top. Curr. Chem.344, 331–345. 10.1007/128_2013_421
88
PassiouraT.KatohT.GotoY.SugaH. (2014). Selection-based Discovery of Druglike Macrocyclic Peptides. Annu. Rev. Biochem.83, 727–752. 10.1146/annurev-biochem-060713-035456
89
PiccirilliJ. A.BennerS. A.KrauchT.MoroneyS. E.BennerS. A. (1990). Enzymatic Incorporation of a New Base Pair into DNA and RNA Extends the Genetic Alphabet. Nature343, 33–37. 10.1038/343033a0
90
PtacinJ. L.CaffaroC. E.MaL.San Jose GallK. M.AerniH. R.AcuffN. V.et al (2021). An Engineered IL-2 Reprogrammed for Anti-tumor Therapy Using a Semi-synthetic Organism. Nat. Commun.12, 4785. 10.1038/s41467-021-24987-9
91
RamakrishnanV. (2002). Ribosome Structure and the Mechanism of Translation. Cell108, 557–572. 10.1016/s0092-8674(02)00619-0
92
RichA. (1962). “Problems of Evolution and Biochemical Information Transfer,” in Horizons Biochem. Editors KashaM.PullmanB. (Academic Press), 103–126.
93
RomesbergF. E. (2022). Creation, Optimization, and Use of Semi-synthetic Organisms that Store and Retrieve Increased Genetic Information. J. Mol. Biol.434, 167331. 10.1016/j.jmb.2021.167331
94
SaitoH.SugaH. (2001). A Ribozyme Exclusively Aminoacylates the 3'-hydroxyl Group of the tRNA Terminal Adenosine. J. Am. Chem. Soc.123, 7178–7179. 10.1021/ja015756s
95
SeoY. J.MalyshevD. A.LavergneT.OrdoukhanianP.RomesbergF. E. (2011). Site-specific Labeling of DNA and RNA Using an Efficiently Replicated and Transcribed Class of Unnatural Base Pairs. J. Am. Chem. Soc.133, 19878–19888. 10.1021/ja207907d
96
SeoY. J.MatsudaS.RomesbergF. E. (2009). Transcription of an Expanded Genetic Alphabet. J. Am. Chem. Soc.131, 5046–5047. 10.1021/ja9006996
97
ShimizuM.AsaharaH.TamuraK.HasegawaT.HimenoH. (1992). The Role of Anticodon Bases and the Discriminator Nucleotide in the Recognition of Some E. coli tRNAs by Their Aminoacyl-tRNA Synthetases. J. Mol. Evol.35, 436–443. 10.1007/BF00171822
98
ShimizuY.InoueA.TomariY.SuzukiT.YokogawaT.NishikawaK.et al (2001). Cell-free Translation Reconstituted with Purified Components. Nat. Biotechnol.19, 751–755. 10.1038/90802
99
SomaA.IkeuchiY.KanemasaS.KobayashiK.OgasawaraN.OteT.et al (2003). An RNA-Modifying Enzyme that Governs Both the Codon and Amino Acid Specificities of Isoleucine tRNA. Mol. Cell12, 689–698. 10.1016/s1097-2765(03)00346-0
100
SteerB. A.SchimmelP. (1999). Major Anticodon-Binding Region Missing from an Archaebacterial tRNA Synthetase. J. Biol. Chem.274, 35601–35606. 10.1074/jbc.274.50.35601
101
SunS. B.SchultzP. G.KimC. H. (2014). Therapeutic Applications of an Expanded Genetic Code. Chembiochem15, 1721–1729. 10.1002/cbic.201402154
102
SuzukiT.MiyauchiK. (2010). Discovery and Characterization of tRNAIlelysidine Synthetase (TilS). FEBS Lett.584, 272–277. 10.1016/j.febslet.2009.11.085
103
SwitzerC.MoroneyS. E.BennerS. A. (1989). Enzymatic Incorporation of a New Base Pair into DNA and RNA. J. Am. Chem. Soc.111, 8322–8323. 10.1021/ja00203a067
104
SyedJ.PalaniS.ClarkeS. T.AsadZ.BottrillA. R.JonesA. M. E.et al (2019). Expanding the Zebrafish Genetic Code through Site-specific Introduction of Azido-Lysine, Bicyclononyne-Lysine, and Diazirine-Lysine. Int. J. Mol. Sci.20, 2577. 10.3390/ijms20102577
105
TanrikuluI. C.SchmittE.MechulamY.GoddardW. A.3rdTirrellD. A. (2009). Discovery of Escherichia coli Methionyl-tRNA Synthetase Mutants for Efficient Labeling of Proteins with Azidonorleucine In Vivo. Proc. Natl. Acad. Sci. U.S.A.106, 15285–15290. 10.1073/pnas.0905735106
106
TorikaiK.SugaH. (2014). Ribosomal Synthesis of an Amphotericin-B Inspired Macrocycle. J. Am. Chem. Soc.136, 17359–17361. 10.1021/ja508648s
107
TsunodaM.KusakabeY.TanakaN.OhnoS.NakamuraM.SendaT.et al (2007). Structural Basis for Recognition of Cognate tRNA by Tyrosyl-tRNA Synthetase from Three Kingdoms. Nucleic Acids Res.35, 4289–4300. 10.1093/nar/gkm417
108
VäreV.EruysalE.NarendranA.SarachanK.AgrisP. (2017). Chemical and Conformational Diversity of Modified Nucleosides Affects tRNA Structure and Function. Biomolecules7, 29. 10.3390/biom7010029
109
VinogradovA. A.YinY.SugaH. (2019). Macrocyclic Peptides as Drug Candidates: Recent Progress and Remaining Challenges. J. Am. Chem. Soc.141, 4167–4181. 10.1021/jacs.8b13178
110
WangK.FredensJ.BrunnerS. F.KimS. H.ChiaT.ChinJ. W. (2016). Defining Synonymous Codon Compression Schemes by Genome Recoding. Nature539, 59–64. 10.1038/nature20124
111
WangL.BrockA.HerberichB.SchultzP. G. (2001). Expanding the Genetic Code of Escherichia coli. Science292, 498–500. 10.1126/science.1060077
112
WangL.SchultzP. G. (2001). A General Approach for the Generation of Orthogonal tRNAs. Chem. Biol.8, 883–890. 10.1016/s1074-5521(01)00063-1
113
WongJ. T. (1983). Membership Mutation of the Genetic Code: Loss of Fitness by Tryptophan. Proc. Natl. Acad. Sci. U.S.A.80, 6303–6306. 10.1073/pnas.80.20.6303
114
YamashigeR.KimotoM.TakezawaY.SatoA.MitsuiT.YokoyamaS.et al (2012). Highly Specific Unnatural Base Pair Systems as a Third Base Pair for PCR Amplification. Nucleic Acids Res.40, 2793–2806. 10.1093/nar/gkr1068
115
YangZ.ChenF.AlvaradoJ. B.BennerS. A. (2011). Amplification, Mutation, and Sequencing of a Six-Letter Synthetic Genetic System. J. Am. Chem. Soc.133, 15105–15112. 10.1021/ja204910n
116
YangZ.ChenF.ChamberlinS. G.BennerS. A. (2010). Expanded Genetic Alphabets in the Polymerase Chain Reaction. Angew. Chem. Int. Ed.49, 177–180. 10.1002/anie.200905173
117
YoungD. D.SchultzP. G. (2018). Playing with the Molecules of Life. ACS Chem. Biol.13, 854–870. 10.1021/acschembio.7b00974
118
YoungT. S.SchultzP. G. (2010). Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon. J. Biol. Chem.285, 11039–11044. 10.1074/jbc.r109.091306
119
ZengY.WangW.LiuW. R. (2014). Towards Reassigning the Rare AGG Codon inEscherichia Coli. Chembiochem15, 1750–1754. 10.1002/cbic.201400075
120
ZhangY.LambB. M.FeldmanA. W.ZhouA. X.LavergneT.LiL.et al (2017a). A Semisynthetic Organism Engineered for the Stable Expansion of the Genetic Alphabet. Proc. Natl. Acad. Sci. U.S.A.114, 1317–1322. 10.1073/pnas.1616443114
121
ZhangY.PtacinJ. L.FischerE. C.AerniH. R.CaffaroC. E.San JoseK.et al (2017b). A Semi-synthetic Organism that Stores and Retrieves Increased Genetic Information. Nature551, 644–647. 10.1038/nature24659
122
ZhouA. X.-Z.DongX.RomesbergF. E. (2020). Transcription and Reverse Transcription of an Expanded Genetic Alphabet In Vitro and in a Semisynthetic Organism. J. Am. Chem. Soc.142, 19029–19032. 10.1021/jacs.0c09230
123
ZhouA. X.-Z.ShengK.FeldmanA. W.RomesbergF. E. (2019). Progress toward Eukaryotic Semisynthetic Organisms: Translation of Unnatural Codons. J. Am. Chem. Soc.141, 20166–20170. 10.1021/jacs.9b09080
Summary
Keywords
translation, genetic alphabet expansion, unnatural amino acid, genetic code expansion, unnatural base pair
Citation
Kimoto M and Hirao I (2022) Genetic Code Engineering by Natural and Unnatural Base Pair Systems for the Site-Specific Incorporation of Non-Standard Amino Acids Into Proteins. Front. Mol. Biosci. 9:851646. doi: 10.3389/fmolb.2022.851646
Received
10 January 2022
Accepted
25 April 2022
Published
24 May 2022
Volume
9 - 2022
Edited by
Nediljko Budisa, University of Manitoba, Canada
Reviewed by
Nikolaj Georg Koch, Technical University of Berlin, Germany
Lluís Ribas De Pouplana, Institute for Research in Biomedicine, Spain
Updates
Copyright
© 2022 Kimoto and Hirao.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Michiko Kimoto, michiko@ibb.a-star.edu.sg; Ichiro Hirao, ichiro@ibb.a-star.edu.sg
This article was submitted to Protein Biochemistry for Basic and Applied Sciences, a section of the journal Frontiers in Molecular Biosciences
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.